245 related articles for article (PubMed ID: 23054640)
1. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
Xu XH; Huang Y; Wang G; Chen SD
Neurosci Bull; 2012 Oct; 28(5):641-8. PubMed ID: 23054640
[TBL] [Abstract][Full Text] [Related]
2. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
Lista S; González-Domínguez R; López-Ortiz S; González-Domínguez Á; Menéndez H; Martín-Hernández J; Lucia A; Emanuele E; Centonze D; Imbimbo BP; Triaca V; Lionetto L; Simmaco M; Cuperlovic-Culf M; Mill J; Li L; Mapstone M; Santos-Lozano A; Nisticò R
Ageing Res Rev; 2023 Aug; 89():101987. PubMed ID: 37343679
[TBL] [Abstract][Full Text] [Related]
3. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
Hurtado MO; Kohler I; de Lange EC
Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the application of metabolomics to Alzheimer's Disease.
Trushina E; Mielke MM
Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
Yi L; Liu W; Wang Z; Ren D; Peng W
Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.
Enche Ady CNA; Lim SM; Teh LK; Salleh MZ; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Abdul Majeed AB; Ramasamy K
J Neurosci Res; 2017 Oct; 95(10):2005-2024. PubMed ID: 28301062
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
8. Omics-based biomarkers discovery for Alzheimer's disease.
Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
[TBL] [Abstract][Full Text] [Related]
10. Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
Luchsinger JA; Zetterberg H
Int Rev Neurobiol; 2020; 154():51-77. PubMed ID: 32739014
[TBL] [Abstract][Full Text] [Related]
11. Discovering Hair Biomarkers of Alzheimer's Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics.
Su YH; Chang CW; Hsu JY; Li SW; Sung PS; Wang RH; Wu CH; Liao PC
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903413
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease in the omics era.
Sancesario GM; Bernardini S
Clin Biochem; 2018 Sep; 59():9-16. PubMed ID: 29920246
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics-based promising candidate biomarkers and pathways in Alzheimer's disease.
Kang J; Lu J; Zhang X
Pharmazie; 2015 May; 70(5):277-82. PubMed ID: 26062293
[TBL] [Abstract][Full Text] [Related]
15. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
16. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
17. Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development.
Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
Curr Neuropharmacol; 2019; 17(7):630-647. PubMed ID: 30255758
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic changes in autopsy-confirmed Alzheimer's disease.
Kaddurah-Daouk R; Rozen S; Matson W; Han X; Hulette CM; Burke JR; Doraiswamy PM; Welsh-Bohmer KA
Alzheimers Dement; 2011 May; 7(3):309-17. PubMed ID: 21075060
[TBL] [Abstract][Full Text] [Related]
20. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
